Neodynamics
0,998 SEK 0%7 investorer følger denne virksomhed
NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden.
Omsætning
320 t
EBIT %
-28.425 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
NEOD
Daglig lav / høj pris
0,998 / 1
SEK
Markedsværdi
32,55 mio. SEK
Aktieomsætning
17,8 t SEK
Volumen
18 t
Analyst
Claus Thestrup
CEO, Sweden
Seneste videoer
Finanskalender
Generalforsamling
22.05.2024
Delårsrapport
20.08.2024
Delårsrapport
19.11.2024
Årsrapport
17.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Gryningskust Holding AB | 32,9 % | 32,9 % |
Rentability Sweden AB | 4,0 % | 4,0 % |
Premium
This content is for our Premium customers only.
Forum opdateringer
ViserAlle indholdstyper
NeoDynamics intends to apply for delisting
NeoDynamics Interim Report Jan-March 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools